Clinical Trial Update: A Study to Assess LBL-007 in Combination With Toripalimab and Axitinib Tablets Subjects With Advanced Melanoma [Phase 1]

View source ↗

Summary

Phase 1 study evaluating LBL-007 in combination with toripalimab and axitinib in advanced melanoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Axitinib (Axitinib)
• LBL-007
• Toripalimab (Toripalimab)

Snippet

Sponsor: Nanjing Leads Biolabs Co.,Ltd | Conditions: Advanced Melanoma | Phase 1 | Status: COMPLETED